Written By: Kriti Saraswat | Published : October 5, 2014 1:19 PM IST
The first Ebola patient in the US from Dallas, Texas, is now critical as reported by cbc.ca. Thomas Duncan whose condition is being monitored closely was serious but stable earlier but the latest reports suggest that his condition is quite critical.
The officials are also monitoring 50 other people who were in close proximity to Duncan and may have contracted the virus from him. 9 of these people including his family members fall under the high-risk category.
Here are a few facts about how he got Ebola:
The patient acquired infection from his landlord s daughter: The New York Times reported that the patient could have acquired the infection from his landlord s daughter in Liberia. He had helped his landlord and his son to carry her to the hospital. She died the next day. Soon, the son also became ill and died.
He flew from Liberia to Texas: The patient, Thomas Duncan, is a Liberian national who flew to Texas to meet his family members on September 20. However, four days after her reached US, he began to develop Ebola symptoms, confirmed Tom Frieden, director of the US Centres for Disease Control and Prevention (CDC).
He s alleged to provide false information at Liberia airport: Reportedly, the patient lied on an airport questionnaire while leaving Liberia about not having any contact with an infected person. Liberia announced its plans to prosecute him for providing false information. Health authorities noted that he had filled out a series of questions about his health and activities before leaving on his journey to Dallas. When the form was obtained on September 19, the Associated Press found that he answered no to all of them. Read more...
With inputs by Shraddha Rupavate
Image source: Getty
You may also like to read:
For more articles on diseases & conditions , visit our diseases & conditions section. Follow us on Facebook and Twitter for all the latest updates! For daily free health tips, sign up for our newsletter. And for health-related queries, visit our Questions and Answers section
